ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 115 filers reported holding ANAPTYSBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $422,000 | -83.8% | 20,783 | -80.3% | 0.00% | -80.0% |
Q1 2022 | $2,613,000 | -38.3% | 105,611 | -13.4% | 0.01% | -37.5% |
Q4 2021 | $4,236,000 | +19.6% | 121,896 | -6.6% | 0.02% | 0.0% |
Q3 2021 | $3,541,000 | +8.2% | 130,560 | +3.5% | 0.02% | +14.3% |
Q2 2021 | $3,272,000 | +99.8% | 126,205 | +66.0% | 0.01% | +100.0% |
Q1 2021 | $1,638,000 | +634.5% | 76,030 | +633.2% | 0.01% | +600.0% |
Q4 2020 | $223,000 | -31.4% | 10,370 | -52.9% | 0.00% | 0.0% |
Q3 2020 | $325,000 | -26.3% | 22,020 | +11.7% | 0.00% | -50.0% |
Q2 2020 | $441,000 | +170.6% | 19,720 | +70.7% | 0.00% | +100.0% |
Q1 2020 | $163,000 | -62.6% | 11,550 | -7.4% | 0.00% | -50.0% |
Q3 2019 | $436,000 | -38.1% | 12,470 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $704,000 | -11.0% | 12,470 | +15.1% | 0.00% | 0.0% |
Q1 2019 | $791,000 | +24.4% | 10,835 | +8.6% | 0.00% | 0.0% |
Q4 2018 | $636,000 | -46.7% | 9,975 | -16.6% | 0.00% | -33.3% |
Q3 2018 | $1,193,000 | -27.9% | 11,960 | -48.6% | 0.01% | -33.3% |
Q2 2018 | $1,655,000 | – | 23,290 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |